Published 60 Day FRN

Attachment F1 Federal Register Notice.pdf

WISEWOMAN National Program Evaluation: Implementation Assessment

Published 60 Day FRN

OMB: 0920-1068

Document [pdf]
Download: pdf | pdf
50653

Federal Register / Vol. 79, No. 164 / Monday, August 25, 2014 / Notices
assessment will be administered to a
total 50 study participants. Information
collection during the extension period
will make it possible to measure
intervention and comparison
participants’ socio-demographic

the HOLA en Grupos intervention.
Collection of the six-month follow-up
assessment information will require
about one hour per study participant.
There is no cost to participants other
than their time.

characteristics, health seeking actions,
HIV/STD and substance use-related risk
behaviors, and psychosocial factors 6
months after they receive the HOLA en
Grupos and comparison interventions,
respectively, and to test the efficacy of

ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
respondent
(in hours)

Total annual
burden
in hours

Form name

Enrolled Study Participant ................

6-month follow-up assessment (att
3).

50

1

1

50

Total ...........................................

...........................................................

........................

........................

........................

50

Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–20103 Filed 8–22–14; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–14–14AUI]

Proposed Data Collections Submitted
for Public Comment and
Recommendations

emcdonald on DSK67QTVN1PROD with NOTICES

Number
responses per
respondent

Number of
respondents

Type of respondent

The Centers for Disease Control and
Prevention (CDC), as part of its
continuing effort to reduce public
burden, invites the general public and
other Federal agencies to take this
opportunity to comment on proposed
and/or continuing information
collections, as required by the
Paperwork Reduction Act of 1995. To
request more information on the below
proposed project or to obtain a copy of
the information collection plan and
instruments, call 404–639–7570 or send
comments to Leroy A. Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to [email protected].
Comments submitted in response to
this notice will be summarized and/or
included in the request for Office of
Management and Budget (OMB)
approval. Comments are invited on: (a)
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the

VerDate Mar<15>2010

17:31 Aug 22, 2014

Jkt 232001

quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. Written comments should
be received within 60 days of this
notice.
Proposed Project
WISEWOMAN National Program
Evaluation—New—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The CDC has supported the
WISEWOMAN program (Well-Integrated
Screening and Evaluation for Women
Across the Nation) since 1995. The
WISEWOMAN program is designed to
serve low-income women ages 40–64
who have elevated risk factors for
cardiovascular disease (CVD) and have
no health insurance, or are
underinsured for medical and
preventive care services. Through the

PO 00000

Frm 00040

Fmt 4703

Sfmt 4703

WISEWOMAN program, women have
access to screening services for selected
CVD risk factors such as elevated blood
cholesterol, hypertension, and abnormal
blood glucose levels; referrals to
lifestyle programs; and referrals to
medical care. WISEWOMAN
participants must be co-enrolled in the
CDC-sponsored National Breast and
Cervical Cancer Early Detection Program
(NBCCEDP).
The WISEWOMAN program is
administered through cooperative
agreements with state, territorial, or
tribal health departments. At present,
approximately two-thirds of program
funding is provided by CDC with the
other one-third supplied by the state,
territory, or tribal organization. Each
WISEWOMAN awardee submits to CDC
an annual progress report that describes
program objectives and activities, and
semi-annual data reports (known as
minimum data elements, or MDE) on
the screening, assessment, and lifestyle
program services offered to women who
participate in the program (see
WISEWOMAN Reporting System, OMB
No. 0920–0612, exp. 12/31/2016).
Participant-level MDE are de-identified
prior to transmission to CDC.
In 2013, CDC released the fourth
funding opportunity announcement
(FOA) for the WISEWOMAN program
(DP13–1302), which resulted in fouryear cooperative agreements with 22
state, territorial, and tribal health
departments, including 5 new and 17
continuing awardees from the previous
FOA. Key program elements were
retained (e.g., provision of screening
services, promotion of healthy lifestyle
behaviors, and linkage to community
resources), but a number of changes
were incorporated into the program at
that time due to shifts in populations,
systems, and community needs. The
current FOA reflects increased emphasis
on improving access to clinical systems
of care and increased emphasis on

E:\FR\FM\25AUN1.SGM

25AUN1

50654

Federal Register / Vol. 79, No. 164 / Monday, August 25, 2014 / Notices

leveraging existing resources in the
community. Lifestyle interventions have
also been reframed to include lifestyle
programs (LSPs) and health coaching
(HC) sessions, and MDE have been
updated to capture information about
risk reduction counseling and
participants’ readiness to change. The
current cooperative agreement also
stresses monitoring and performance
evaluation as key program dimensions.
Additionally, more information is
needed to augment that from previous
evaluation efforts.
CDC seeks to conduct a one-time,
multi-component evaluation to assess
the effectiveness of the program on

programs, administered in the second
and fourth program years; a Network
Survey of WISEWOMAN awardees and
partner organizations, also conducted in
the second and fourth program years;
and a one-time Site Visit to a subset of
awardees across the second to fourth
program years. During site visits, semistructured interviews will be conducted
with WISEWOMAN staff members who
serve in diverse roles and are positioned
to provide a variety of perspectives on
program implementation.
OMB approval is requested for three
years. Participation is voluntary and
there are no costs to respondents other
than their time.

individual-, organizational-, and
community-level outcomes. The indepth assessment is designed to
complement the routine progress and
MDE information already being
collected from WISEWOMAN program
awardees. The new data collection will
focus on obtaining qualitative and
quantitative information at the
organizational and community levels
about process and procedures
implemented, and barriers, facilitators,
and other contextual factors that affect
program implementation and
participant outcomes. Data collection
activities will include a Program Survey
with all WISEWOMAN awardee

ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden
per response
(in hours)

Total burden
(in hours)

Form name

WISEWOMAN Awardee Administrators.

Program Survey ...............................

15

1

70/60

18

Healthy Behavior Support staff .........
Clinical Providers ..............................

Network Survey ................................
Site Visit Interview Guide .................
Network Survey ................................
Site Visit Interview Guide .................
Site Visit Interview Guide .................
Site Visit Interview Guide .................

15
6
147
12
12
12

1
1
1
1
1
1

50/60
75/60
50/60
45/60
45/60
45/60

13
8
123
9
9
9

Total ...........................................

...........................................................

........................

........................

........................

189

Awardee Partners .............................

Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–20101 Filed 8–22–14; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
ICD–10 Coordination and Maintenance
(C&M) Committee
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of public meeting.
National Center for Health Statistics
(NCHS), Classifications and Public
Health Data Standards Staff, announces
the following meeting.
AGENCY:

emcdonald on DSK67QTVN1PROD with NOTICES

Number of
responses per
respondent

Number of
respondents

Type of respondents

Name: ICD–10 Coordination and
Maintenance (C&M) Committee meeting.
DATES: Time and Date: 9:00 a.m.–5:00
p.m., EDT, September 23–24, 2014.
Place: Centers for Medicare and
Medicaid Services (CMS) Auditorium,

VerDate Mar<15>2010

17:31 Aug 22, 2014

Jkt 232001

7500 Security Boulevard, Baltimore,
Maryland 21244.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 240
people. We will be broadcasting the
meeting live via Webcast at http://
www.cms.gov/live/.
Security Considerations: Due to
increased security requirements CMS
has instituted stringent procedures for
entrance into the building by nongovernment employees. Attendees will
need to present valid government-issued
picture identification, and sign-in at the
security desk upon entering the
building.
Attendees who wish to attend the
September 23–24, 2014, ICD–10 C&M
meeting must submit their name and
organization by September 12, 2014, for
inclusion on the visitor list. This visitor
list will be maintained at the front desk
of the CMS building and used by the
guards to admit visitors to the meeting.
Participants who attended previous
Coordination and Maintenance meetings
will no longer be automatically added to
the visitor list. You must request
inclusion of your name prior to each
meeting you wish attend.

PO 00000

Frm 00041

Fmt 4703

Sfmt 4703

Please register to attend the meeting
on-line at: http://www.cms.hhs.gov/
apps/events/.
Please contact Mady Hue (410–786–
4510 or [email protected]), for
questions about the registration process.
Purpose: The ICD–10 Coordination
and Maintenance (C&M) Committee is a
public forum for the presentation of
proposed modifications to the
International Classification of Diseases,
Tenth Revision, Clinical Modification
and ICD–10 Procedure Coding System.
Matters for Discussion: Tentative
agenda items include:
September 23–24, 2014
ICD–10–PCS Topics:
Hip and Knee Replacements
Face Transplants
Hand Transplants
Laparoscopic-assisted Pull-Through
(Swenson)
Administration of CeftazidimeAvibactam
Drug Coated Balloon Angioplasty
Minimally Invasive Cardiac Valve
Surgery
Addenda and Key Updates
ICD–10–CM Diagnosis Topics:
Observation and evaluation of newborns
for suspected condition not found
Sarcopenia

E:\FR\FM\25AUN1.SGM

25AUN1


File Typeapplication/pdf
File Title2014-20101.pdf
Authorarp5
File Modified2014-08-25
File Created2014-08-25

© 2024 OMB.report | Privacy Policy